Listed

PharmaCyte Biotech, Inc.

PMCBNasdaqCIK 1157075HealthcareFiscal year ends Apr 30

Reports and events: 211 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

PharmaCyte Biotech, Inc., Reports and events
FiledFormWhat it isAccession number
2019-08-1321:57 ET10-KAnnual reportPeriod 2019-04-300001683168-19-002559
2019-03-1417:21 ET10-QQuarterly reportPeriod 2019-01-310001683168-19-000666
2018-12-1417:28 ET10-QQuarterly reportPeriod 2018-10-310001683168-18-003717
2018-09-1217:23 ET10-QQuarterly reportPeriod 2018-07-310001683168-18-002721
2018-07-2017:08 ET10-KAnnual reportPeriod 2018-04-300001683168-18-001994
2018-05-1518:43 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001683168-18-001309
2018-03-1916:37 ET10-QQuarterly reportPeriod 2018-01-310001683168-18-000720
2018-02-2216:18 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits0001683168-18-000494
2017-12-1416:48 ET10-QQuarterly reportPeriod 2017-10-310001683168-17-003310
2017-10-1008:30 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001683168-17-002610
2017-09-1320:34 ET10-QQuarterly reportPeriod 2017-07-310001683168-17-002358
2017-09-0608:00 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001683168-17-002311
2017-07-2717:22 ET10-KAnnual reportPeriod 2017-04-300001683168-17-001881
2017-07-1006:03 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001683168-17-001742
2017-05-0208:07 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001683168-17-001069
2017-03-1308:38 ET10-Q/AQuarterly report, amendedPeriod 2017-01-310001683168-17-000544
2017-03-1308:02 ET10-QQuarterly reportPeriod 2017-01-310001683168-17-000541
2016-12-2106:01 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001683168-16-001004
2016-12-0217:26 ET10-QQuarterly reportPeriod 2016-10-310001683168-16-000848
2016-09-0617:16 ET10-QQuarterly reportPeriod 2016-07-310001683168-16-000026
2016-07-2917:25 ET10-KAnnual reportPeriod 2016-04-300001019687-16-007057
2016-03-0817:31 ET10-QQuarterly reportPeriod 2016-01-310001019687-16-005399
2016-03-0217:00 ET10-K/AAnnual report, amendedPeriod 2015-04-300001019687-16-005316
2016-01-1917:32 ET10-K/AAnnual report, amendedPeriod 2015-04-300001019687-16-004873
2016-01-1917:30 ET10-Q/AQuarterly report, amendedPeriod 2015-10-310001019687-16-004872
2016-01-1906:14 ET10-Q/AQuarterly report, amendedPeriod 2015-10-310001019687-16-004860
2016-01-1906:11 ET10-Q/AQuarterly report, amendedPeriod 2015-07-310001019687-16-004858
2016-01-1906:08 ET10-K/AAnnual report, amendedPeriod 2015-04-300001019687-16-004856
2016-01-1217:16 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001019687-16-004784
2015-12-3109:23 ET8-K4.02 Non-reliance on financial statements; 5.02 Departure or appointment of officers or directors0001019687-15-004674
2015-12-1016:47 ET10-QQuarterly reportPeriod 2015-10-310001019687-15-004472
2015-11-0216:14 ET8-K4.01 Change of auditor; 9.01 Financial statements and exhibits0001019687-15-003870
2015-10-0217:00 ET8-K5.02 Departure or appointment of officers or directors0001019687-15-003617
2015-08-2517:40 ET10-QQuarterly reportPeriod 2015-07-310001019687-15-003255
2015-07-2916:02 ET10-KAnnual reportPeriod 2015-04-300001019687-15-002894
2015-05-2817:32 ET8-K4.01 Change of auditor; 9.01 Financial statements and exhibits0001019687-15-002167
2015-04-2909:00 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001019687-15-001655
2015-03-1317:21 ET10-QQuarterly reportPeriod 2015-01-310001019687-15-000953
2015-01-0911:33 ET8-K5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001019687-15-000112
2014-12-1516:50 ET10-QQuarterly reportPeriod 2014-10-310001019687-14-004716
2014-12-0109:30 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001019687-14-004534
2014-10-1718:46 ET10-K/AAnnual report, amendedPeriod 2014-04-300001019687-14-003893
2014-10-1718:45 ET10-K/AAnnual report, amendedPeriod 2013-04-300001019687-14-003892
2014-10-0317:15 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001019687-14-003787
2014-09-2509:07 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.05 Item not in the standard list; 8.01 Other events; 9.01 Financial statements and exhibits0001019687-14-003701
2014-09-1508:24 ET10-QQuarterly reportPeriod 2014-07-310001019687-14-003582
2014-08-0408:12 ET10-KAnnual reportPeriod 2014-04-300001019687-14-002942
2014-05-2918:22 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits0001019687-14-002185
2014-03-2519:13 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001019687-14-000974
2014-03-2008:28 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001019687-14-000911

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 20:52 ET. Listed shows no prices and gives no investment advice.